Patent · US Expired

(R) 2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1 (pyrrolidinocarbonyl)-ethyl]-benzimidazole, the monohydrochloride thereof, preparation thereof and the use as pharmaceutical composition

US7169934B2 · kind B2 · utility

0Cited by

1References

2Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Guenter Linz · Mittelbiberach, DE
Peter Sieger · Mittelbiberach, DE
Gunnar Schreiner · Biberach, DE
Werner Rall · Mittelbiberach, DE
Rolf Schmid · Gelterkinden, CH

Key dates

Filing date	Jun 17, 2003
Grant date	Jan 30, 2007
Priority date	—
Expiry date	Jan 4, 2024

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D235/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Crystalline forms of the compounds (R)-2-(4-amidinophenylaminomethyl)-1-methyl-5-[1-(carboxymethylamino)-1-(pyrrolidinocarbonyl)-ethyl]-benzimidazole and the monohydrochloride thereof, processes for the preparation thereof and the use thereof as pharmaceutical compositions.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.